Article
Identification of JAK2 mutations in canine primary polycythemia.
Experimental hematology - 1 May 2011
Beurlet Stephanie, Krief Patricia, Sansonetti Arnaud, Briend-Marchal Alexandra, Kiladjian Jean-Jacques, Padua Rose Ann, Chomienne Christine, Cassinat Bruno
Abstract excerpt
OBJECTIVE: Primary polycythemia in dogs is classified as a myeloproliferative syndrome with a chronic progressive course and unspecific symptoms. Diagnosis is based on exclusion criteria. In humans, the presence of an acquired recurrent mutation within the JAK2 gene has recently been identified in 90% of the patients with polycythemia vera. This mutation (V617F) is located in the pseudokinase domain of JAK2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.